📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Genetic consequences of effective and suboptimal dosing with mutagenic drugs in a hamster model of SARS-CoV-2 infection. (2024)

First Author: Illingworth CJR

Attributed to: MRC Centre for Virus Research (MRC CVR) - COVID-19 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ve/veae001

PubMed Identifier: 38486802

Publication URI: http://europepmc.org/abstract/MED/38486802

Type: Journal Article/Review

Volume: 10

Parent Publication: Virus evolution

Issue: 1

ISSN: 2057-1577